北京
利弗莫爾證券顯示，北京質肽生物醫藥科技股份有限公司向港交所提交上市申請書，聯席保薦人為杰富瑞、華泰國際。
本文源自：金融界AI電報
特別聲明：以上內容(如有圖片或視頻亦包括在內)為自媒體平臺“網易號”用戶上傳并發布，本平臺僅提供信息存儲服務。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
